Emilio Merlo-Pich

Modelling placebo response in depression trials using a longitudinal model with informative dropout.

R. Gomeni, E. Merlo-Pich, Roberto Gomeni, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment

John Suckling, Chi-Hua Chen, Khanum Ridler, 2007, Biological Psychiatry.

Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials.

R. Gomeni, E. Merlo-Pich, Roberto Gomeni, 2007, British journal of clinical pharmacology.

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

John D. Beaver, Mark Slifstein, Marc Laruelle, 2010, Biological Psychiatry.

Structural Brain Changes in Patients with Recurrent Major Depressive Disorder Presenting with Anxiety Symptoms

Thomas E. Nichols, Dorothee P Auer, Paul M Matthews, 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: Initial validation of an imaging protocol for drug discovery

Jesús Pujol, Carles Soriano-Mas, Paolo Fina, 2014, European Neuropsychopharmacology.

Differential Effect of Orexin-1 and CRF-1 Antagonism on Stress Circuits: a fMRI Study in the Rat with the Pharmacological Stressor Yohimbine

Angelo Bifone, Alessandro Gozzi, Stefano Lepore, 2013, Neuropsychopharmacology.

Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

Edward T. Bullmore, Lefkos Middleton, Florian Holsboer, 2010, PloS one.